1.The Efficacy of Prostate Biopsy by Use of the Vienna nomogram. Won Ik Seo, Sung Hyup Choi, Jae Il Chung. Korean J Urology 2009 Dec 50(12): 1168-1173.

2.Simultaneous Occurrence of Chromophobe Renal Cell Carcinoma and Urothelial Carcinoma in the Same Kidney. Ik Joon Choi, Sung Hwan Jung, Won Ik Seo, Pil Moon Kang, Soo Jin Jung1, Jae Il Chung. Korean J Urology. 2009 May 050(05): 508-511.

3.Renal Intracystic Massive Hemorrhage after Blunt Trauma. Pil Moon Kang, Won Ik Seo, Ik Joon Choi, Sung Hwan Jung, Ho Sup Kwak, Auh Whan Park1, Soo Jin Jung2, Dong Il Kang. Korean J Urology 2008 Oct 049(10): 953-956.

4.Korean prostate cancer patients have worse disease characteristics than their American counterparts. Kang DI, Chung JI, Ha HK, Min K, Yoon J, Seo WI, Kang PM, Jung SJ, Kin IY. Asian Pac J Cancer Prev 2013;14(11):6913-7.

5.Predictive value of the cancer or the prostate risk assessment score for recurrence-free survival after radical prostatectomy in Korea: a single-surgeon series. Seo WI, Kang PM, Chung JI. Karean J Urology 2014 May;55(5):321-6.

6.Thulium laser(RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: A propensity-matched multicenter analysis. Chung JS, Kang PM, Seo WI, Oh CK, Kim SC, Park SH, Choi JH, Yoon JH, Kang DI, Chung JI. Int J Urol 2014 Nov;21(11):1156-61.

7.Cancer or the Prostate Risk Assessment(CAPRA) Preoperative Score versus Postoperative score(CAPRA-S):ability of predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy. Seo WI, Kang PM, Kang DI, YoonJH, Kim W, Chung JI. J Korean Med Sci. 2014 Sep;29(9):1212-6.

8.Incidental Abnormal FDG uptake in the prostate on 18-fluoro-2-Deoxyglucose Positron Emission Tomography-Computed Tomography Scans. Kang PM, Seo WI, Lee SS, Bae SK, Kwak HS, Min K, Kim W, Kang DI. Asian Pac J Cancer Prev. 2014;15(20):8699-703.

9. Primary androgen deprivation therapy for prostate cancer in koreans: a retrospective multicenter study. Seo WI, Kang PM, Kim TH, Moon KH, Chung JM, Lee DH, Kim IY, Min K, Chung J, Kim W, Kang DI. World J Mens Health. 2014 Dec;32(3):159-66.

10. Transutricular seminal vesiculoscopy in the management of symptomatic midline cyst of the prostate.KangPM,Seo WI, Yoon JH, Kim TS, Chung JI. World J Urol. 2016 Jul;34(7):985-92

11. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.Seo WI, Park S, Gwak J, Ju BG, Chung JI, Kang PM, Oh S.Biochem Biophys Res Commun. 2017 May 13;486(4):1034-1039.

12. Correlation between postoperative prostate-specific antigen and biochemical recurrence in positive surgical margin patients: Single surgeon series. Seo WI, Kang PM, Yoon JH, Kim W, Chung JI.Prostate Int. 2017 Jun;5(2):53-58.

13. Longitudinal changes in erectile function after thulium:YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study. Chung JS, Park SH, Oh CK, Kim SC, Kim TS, Kang PM, Seo WI, Kim WS, Yoon JH, Kang DI, Min KS, Chung JI.

14. Laparoscopic -2port Varicocelectomy with Scarless Periumblical Mini-Incision: Initial Experience in Approach and Outcomes. Seo WI, Kwon JK, Kang PM, Kim W, Yoon JH, Kim TS, Chung JS, Oh CK. Urol J. 2018 Mar18;15(2):10-15.

15. Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia. Kang PM, Kim YJ, Seo WT, Kang SH, Kim TS, Chun BK, Seo WI, Jeong JY, Chung JI. World J Urol. 2019 Apr;37(4):709-718.

16. The superiority of contact surface area as a predictor of renal cortical volume change after partial nephrectomy compared to RENAL, PADUA and C-index: an approach using computed tomography-based renal volumetry. Lee CH, Ku JY, Park YJ, Seo WI, Ha HK. Scand J Urol. 2019 Apr-Jun;53(2-3):129-133.

17. Effect of Converting From Calcineurin Inhibitor- to Sirolimus-Based Immunosuppressant Regimen on Breast Fibroadenoma Among Kidney Transplant Patients. Kim MJ, Kim BW, Yoon YC, Seo WI, Park YM, Kang SW, Kim TH, Kim YH. Transplant Proc. 2019 Jul-Aug;51(6):1848-1852.

18. Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia. Chung JS, Seo WI, Oh CK, Kim SC, Park MC, Park SH, Yu J, Lee CH, Kim W, Park TY, Min KS, Chung JI. Investig Clin Urol. 2020 Jan;61(1):67-74.

19. Role of Prior Split Renal Function for Living Kidney Transplantation in Recipients and Donors. Seo WI, Lee CH, Park TY, Kim W, Min K, Chung JI, Park YH, Kang SW, Kim YH, Kim MJ, Kim Y, Kim T. Transplant Proc. 2020 Dec;52(10):3002-3008.

20. Clinical factors that influence the occurrence of symptomatic pseudoaneurysms and arteriovenous fistulas after partial nephrectomy: multi-institutional study of renal function outcomes after one year of selective arterial embolization. Lee CH, Ha HK, Ku JY, Seo WI, Choi SH.

Int Braz J Urol. 2021 Jan-Feb;47(1):149-158.

21. Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis. Cho H, Chung JI, Kim J, Seo WI, Lee CH, Morgan TM, Byun SS, Chung JS, Han KH. Cancer Sci. 2021 Feb;112(2):859-870.

22. Prognostic significance of sarcopenia and decreased relative dose intensity during the initial two cycles of first-line sunitinib for metastatic renal cell carcinoma. Lee CH, Ku JY, Seo WI, Park YJ, Chung JI, Kim W, Park TY, Ha HK. J Chemother. 2021 Jul;33(4):245-255.

23. Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database. Lee CH, Chung J, Kwak C, Jeong CW, Seo SI, Kang M, Hong SH, Song C, Park JY, Hwang EC, Lee H, Ku JY, Seo WI, Choi SH, Ha HK; Korean Renal Cancer Study Group. Int J Urol. 2021 Apr;28(4):417-423.